Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Jean L, VAN Laethem"'
Autor:
Bert, VAN DEN Heuvel, Marc, Peeters, Alain, Hendlisz, Marc, VAN DEN Eynde, Godelieve, Machiels, Isabel, Dero, Karen, Geboes, Marc, DE Man, Koen, Hendrickx, Thierry, Delaunoit, Els, Monsaert, Erik, Vanderstraten, Jean L, VAN Laethem, Willem, Lybaert, Stephane, Holbrechts, Christian, Rolfo
Publikováno v:
Minerva chirurgica.
The aim of this study is to investigate the role of Octreotide LAR in secondary prevention in patients with chemotherapy-induced diarrhea.In this study, patients experiencing CID ≥ grade 2 received 30 mg long-acting octreotide as a monthly injectio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::69d64304d4d8714c6c84f8eebc27c4b6
https://pubmed.ncbi.nlm.nih.gov/26771252
https://pubmed.ncbi.nlm.nih.gov/26771252
Autor:
Richard M. Goldberg, Frank A. Sinicrope, Thomas C. Smyrk, Pierre Laurent-Puig, Enrico Mini, Aziz Zaanan, Karine Le Malicot, Gunnar Folprecht, Catherine Julié, Daniel J. Sargent, Jean L. Van Laethem, Josep Tabernero, Steven R. Alberts, Julien Taieb, Ayman Zawadi, Qian Shi
Publikováno v:
Journal of Clinical Oncology. 33:3506-3506
3506 Background: The prognostic impact of deficient (d) MMR, including sporadic and familial types, in stage III colon cancer pts receiving standard adjuvant FOLFOX therapy remains unknown. We exam...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d71acb836f3c11d9ddf68c680f207078
https://doi.org/10.1200/jco.2015.33.15_suppl.3506
https://doi.org/10.1200/jco.2015.33.15_suppl.3506